Synthesis and Structure-Activity Studies of a Series of 1-Oxa-8-azaspiro[4.5]decanes as M_1 Muscarinic Agonists
スポンサーリンク
概要
- 論文の詳細を見る
2,8-Dimethyl-1-oxa-8-azaspiro[4.5]decan-3-one (17), designed by incorporating the tetrahydrofuran ring moiety of muscarone into an 8-azaspiro[4.5]decane skeleton, and related 1-oxa-8-azaspiro[4.5]decanes were synthesized and assessed as M_1 muscarinic agonists for the symptomatic treatment of dementia of Alzheimer's type. The compounds were tested for central muscarinic M_1 and M_2 receptor affinity and in vivo muscarinic activities : namely, amelioration of scopolamine-induced impairment in rat passive avoidance tasks, and induction of hypothermia, tremor, and salivary secretion. Compound 17 exhibited potent muscarinic activities in vitro and in vivo with no selectivity. Systematic modifications of 17 were conducted, and a number of compounds, including the 2-ethyl analogue (18), 3-methylene analogue (29), 3-dithioketal analogues (26,28), and 3-oxime analogue (37) were found to display preferential affinity for M_1 receptors over M_2 receptors and, in addition, to exhibit potent antiamnesic activity sufficiently separated from hypothermia-inducing activity, taken as an index of cholinergic side effects, compared with the reference compound RS86 (1). Structure-activity relationships are discussed in comparison with those for muscarone analogues. Of these compounds only two, 2-ethyl-8-methyl-1-oxa-8-azaspiro[4.5]decan-3-one (18) and 2,8-dimethyl-3-methylene-1-oxa-8-azaspiro[4.5]decane (29), stimulated phosphoinositide hydrolysis in rat hippocampal slices, indicating partial agonistic activity for M_1 muscarinic receptors.The optical resolution of 18 and 29 was performed. Eudismic ratios of both compounds in binding affinity were low, but M_1 agonist activity resided preferentially in the (-)-isomers. The absolute configuration of (-)-29 was determined by X-ray crystal structure analysis to be S, being the same as that of muscarone. Based on the in vivo selectivity, (-)-29 was selected for clinical studies.
- 公益社団法人日本薬学会の論文
- 1995-05-15
著者
-
塚本 紳一
Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.,
-
Furuya Toshio
Institute For Drug Discovery Research Yamanouchi Pharmaceutical Co. Ltd.
-
藤井 光夫
Institute For Drug Discovery Research Yamanouchi Pharmaceutical Co. Ltd.
-
塚本 紳一
Institute For Drug Discovery Research Yamanouchi Pharmaceutical Co. Ltd.
-
安永 智之
Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.,
-
松田 光陽
Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.,
-
松田 光陽
Institute For Drug Discovery Research Yamanouchi Pharmaceutical Co. Ltd.
-
Tsukamoto Shin-ichi
Institute For Drug Discovery Research Yamanouchi Pharmaceutical Co. Ltd.
-
安永 智之
Osaka Univ. Osaka Jpn
-
Hidaka K
Institute For Drug Discovery Research Yamanouchi Pharmaceutical Co. Ltd.
-
WANIBUCHI Fumikazu
Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.
-
HIDAKA Kazuyuki
Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.
-
TAMURA Toshinari
Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.
-
Tamura Toshinari
Institute For Drug Discovery Research Yamanouchi Pharmaceutical Co. Ltd.
-
Wanibuchi Fumikazu
Institute For Drug Discovery Research Yamanouchi Pharmaceutical Co. Ltd.
関連論文
- Synthesis and Structure-Activity Studies of a Series of 1-Oxa-2,8-diazaspiro[4.5]decan-3-ones and Related Compounds as M_1 Muscarinic Agonists
- Synthesis and Structure-Activity Relationships in a Series of Ethenesulfonamide Derivatives, a Novel Class of Endothelin Receptor Antagonists
- Ethenesulfonamide Derivatives, a Novel Class of Orally Active Endothelin-A Receptor Antagonists
- Novel Malonamide Derivatives as α_vβ_3 Antagonists.Syntheses and Evaluation of 3-(3-Indolin-1-yl-3-oxopropanoyl)aminopropanoic Acids on Vitronectin Interaction with α_vβ_3
- Synthesis and Structure-Activity Studies of a Series of 1-Oxa-8-azaspiro[4.5]decanes as M_1 Muscarinic Agonists